# PA-915 anxiety molecule hyped online, but human trials years away

2026-08-10T09:49:54+00:00 | Health & Science | Indian Opinion Desk

Corroboration: 1 independent outlet

Social media is calling PA-915 a 'revolutionary anti-anxiety vaccine', but the molecule is not a vaccine and has only been tested in mice. Developed by Japanese researchers, PA-915 blocks the brain's PAC1 stress receptor and showed reduced anxiety-like symptoms in rodents for up to eight weeks with no reported side effects. Millennium Post reports that no human clinical trials have begun, and the journey from animal studies to an approved drug typically takes many years. Mental health experts warn that confusing experimental compounds with established treatments can deter people from seeking therapy or medications that work today.

## Coverage

- millenniumpost.in <https://www.millenniumpost.in/sunday-post/wellness/one-injection-to-silence-anxiety-661244>

Tags: anxiety, clinical trials, mental health, neuroscience, PA-915, social media hype
Canonical: https://indianopinion.org/pa-915-anxiety-molecule-hyped-online-but-human-trials-years-away/
License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources.
Cite: https://indianopinion.org/pa-915-anxiety-molecule-hyped-online-but-human-trials-years-away/#story-in-brief

Review state: restored archive article, accurate at time of publication, not offered to search indexes.
